Home / Companies / Axovia Therapeutics Inc / Roles
Axovia Therapeutics Inc H-1B role rows
Row-level LCA role declarations for Axovia Therapeutics Inc, including title, SOC code, worksite, status, date fields, wage offer, prevailing wage, and source record evidence. Showing 1 returned rows using keyset pagination.
Summary
This view lists 1 H-1B LCA role records.
Offered wages among the returned rows range from $270,853 to $400,000.
Employers in the returned rows include Axovia Therapeutics, Inc..
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Role | Employer | SOC | Status / visa | Decision | Worksite | Offered wage | Prevailing wage | Source |
|---|---|---|---|---|---|---|---|---|
| Chief Financial Officer I-203-21308-687091 | Axovia Therapeutics, Inc. | 11-1011.00 Chief Executives | Certified / E-3 Australian FY2022 | 2021-11-12 2022-01-01 to 2023-12-31 | New York, NY, 10010 | $270,853 to $400,000 year | $208,000 | sr_dol_oflc_lca_2022_q1_row_057407 |
End of returned pageReset
Frequently asked questions
- What are the offered H-1B wages for Axovia Therapeutics Inc H-1B role rows?
- Offered wages among the returned Axovia Therapeutics Inc H-1B role rows rows range from $270,853 to $400,000 in DOL LCA filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/roles?limit=50&company=axovia+therapeutics+incJSON